L-Cin 750 Tablet contains Levofloxacin 750 mg, a broad-spectrum fluoroquinolone antibiotic effective against a wide range of gram-positive and gram-negative bacterial infections. It is primarily indicated for the treatment of respiratory tract infections, including community-acquired pneumonia, chronic bronchitis exacerbations, and sinusitis, as well as urinary tract infections, acute pyelonephritis, skin and soft tissue infections, and prostatitis. Levofloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for DNA replication, transcription, repair, and recombination, resulting in bacterial cell death. The 750 mg dosage is typically reserved for more severe infections or those caused by less susceptible organisms, ensuring optimal therapeutic levels and clinical efficacy. L-Cin 750 should be administered orally once daily, with or without food, as prescribed by a healthcare professional. Caution is advised in patients with a history of tendon disorders related to fluoroquinolone use, renal impairment, or QT interval prolongation. Common adverse effects may include gastrointestinal disturbances, headache, dizziness, and photosensitivity. It is essential to complete the full prescribed course to prevent resistance development. L-Cin 750 is contraindicated in patients with known hypersensitivity to levofloxacin or other quinolones.